ADM has announced it will invest approximately $300 million to expand its Decatur, Ill., alternative protein production and open a new, state-of-the-art Protein Innovation Center, as the company continues to add capacity and further enhance its alternative protein capabilities to meet strong demand growth.
The production increase represents a significant expansion of ADM’s alternative protein capabilities. The project will significantly strengthen ADM’s ability to meet growing global demand by increasing soy protein concentrate capacity and nearly doubling extrusion capacity at ADM’s Decatur complex.
The enhancements will improve production capabilities by utilizing the latest cutting-edge technologies and processes, including best-available control technology in line with ADM’s commitments to environmentally sustainable operations.
 | FDA Proposed Rule for Traceability--Are You Prepared? |
The Protein Innovation Center will expand ADM’s Decatur-based innovation complex, joining the company’s Food Application Center and Animal Nutrition Technology Center and enhancing the company’s ability to work closely with customers to develop custom solutions to meet their needs. The new Decatur Innovation Center will bring together labs, test kitchens, and pilot-scale production capabilities to power new innovation, from novel and diversified ingredients, to more sustainable and efficient processing, to unique and differentiated texture, taste, appearance, and nutrition solutions.
The project—which is expected to be completed in the first quarter of 2025, subject to all applicable approvals and permits—is the latest to expand ADM’s global alternative protein production capacity. Last year, the company acquired Sojaprotein, a leading European provider of non-GMO human nutrition protein solutions. Between the two investments, ADM will increase its global alternative protein production capacity by more than 30%.
